Our CEO, Simone Leyden raises awareness around neuroendocrine cancer, discusses the recent passing of Irrfan Khan and chats about #LetsWalkforNETs with Ticker Newsroom
Our CEO, Simone Leyden raises awareness around neuroendocrine cancer, discusses the recent passing of Irrfan Khan and chats about #LetsWalkforNETs with Ticker Newsroom
Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.
Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.
Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.